← Back to Patent Explorer
US6476205B1 Expired / Lapsed US ⏱️ 0.0 years remaining

2′ Modified oligonucleotides

Assignee: Ionis Pharmaceuticals Inc
•
Filing: 1998-08-10
•
Granted: 2002-11-05
•
Expires: 2018-08-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Oligomers which have substituents on the 2' position are resistant to oligonucleases and furthermore can be derivatized to deliver reagents or drugs, to carry label, or to provide other properties.

Inventors

  • 👤 Chris A. Buhr
  • 👤 Mark Matteucci

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 21:40
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/113; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/06; C07H19/10; C07H19/16; C07H19/20; C07H21/00; C12N2310/00; C12N2310/30; C12N2310/32; C12N2310/321; C12N2310/322; C12N2310/35; C12N2310/351; C12N2310/3517; C12N2310/352; C12N2310/3527; C12N2310/353; C12N2310/3535

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 177 words
An oligonucleotide having the formula: or a salt thereof, wherein: each B independently is a protected or unprotected purine or pyrimidine base in the β-anomeric configuration; W 3 and W 4 are each independently H, PO 3 −2 , a protecting group, or an intermediate moiety in the formation of an internucleotide link which when reacted with the appropriate —OH results in Z; n is an integer of 1-200; each Z is independently is P(O)O, P(O)S or P(O)N(R) 2 provided at least one Z is not P(O)O; each R is independently H or alkyl (C 1-6 ); each A is OCH 3 , H, OH, O—Pr wherein Pr is a protecting group, or X—Y wherein: X is O; and Y is substituted or unsubstituted alkyl (C 2-20 ) or substituted or unsubstituted alkenyl (C 2-20 ), wherein the substituents are a halogen, OH, NH 2 , SH, —O—, —CH 2 CONH 2 , —CH 2 COOCH 2 CH 3 , or CH 2 CONHCH 2 NH 2 ; and at least one A is OCH 3 .
Claim 2
Dependent Claim 177 words
An oligonucleotide having the formula: or a salt thereof, wherein: each B independently is a protected or unprotected purine or pyrimidine base in the β-anomeric configuration; W 3 and W 4 are each independently H, PO 3 −2 , a protecting group, or an intermediate moiety in the formation of an internucleotide link which when reacted with the appropriate —OH results in Z; n is an integer of 1-200; each Z is independently is P(O)O, P(O)S or P(O)N(R) 2 provided at least one Z is not P(O)O; each R is independently H or alkyl (C 1-6 ); each A is OCH 3 , H, OH, O—Pr wherein Pr is a protecting group, or X—Y wherein: X is O; and Y is substituted or unsubstituted alkyl (C 2-20 ) or substituted or unsubstituted alkenyl (C 2-20 ), wherein the substituents are a halogen, OH, NH 2 , SH, —O—, —CH 2 CONH 2 , —CH 2 COOCH 2 CH 3 , or CH 2 CONHCH 2 NH 2 ; and at least one A is OCH 3 .
Claim 3
Dependent Claim 13 words
The oligonucleotide of claim 1 wherein W 3 and W 4 are H.
Claim 4
Dependent Claim 14 words
The oligonucleotide of claim 1 wherein at least one Z is P(O)N(R) 2 .
Claim 5
Dependent Claim 12 words
The oligonucleotide of claim 1 wherein at least one Z is P(O)S.
Claim 6
Dependent Claim 12 words
The oligonucleotide of claim 1 wherein at least one A is X—Y.
Claim 7
Dependent Claim 10 words
The oligonucleotide of claim 5 wherein Y is substituted alkyl.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2005-11-04 2006-05-06 2006-11-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2009-11-04 2010-05-06 2010-11-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2013-11-04 2014-05-06 2014-11-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag